Synaffix
synaffix.com
Actively hiring
Biologics & Biosimilars
Health Care
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
BioGeneration Ventures, M Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
M Ventures Overview
Lonza’s ADC technology enables site-specific conjugation for stable, high-performing antibody-drug conjugates supporting bioconjugate development.